Remove about
article thumbnail

Walmart: Turning San Diego Into Its Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego?

San Diego 100
article thumbnail

Walmart: Turning San Diego Into A Key Technology Center

socalTECH

However, the company's technology team, Walmart Labs (www.walmartlabs.com)--which said this month that it is planning on major growth in San Diego is responsible for the company's key supply chain technology, online e-commerce site, and much more. What exactly does Walmart Labs work on in San Diego?

San Diego 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Xconomy

Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM ) struck a deal to raise up to $80 million in a private placement. percent premium, or about $1 more per share than the previous day’s closing price, for about 6.6 million shares. million shares.

article thumbnail

Xconomy Guide to Best Sessions at Startup Week San Diego

Xconomy

Startup Week San Diego, like a lot of other places that host similar events, has been billed as a weeklong celebration of entrepreneurship. But while Startup Week San Diego has always collaborated with UP Global, San Diego entrepreneur and Startup Week organizer Austin Neudecker said, “We’ve always been an independent entity.”.

article thumbnail

Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments

Xconomy

A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA. The company, which CEO Bob Manning says has raised about $2.5

article thumbnail

How long can Zuckerberg afford to bankroll the AR/VR market?

TechCrunch LA

Last week, we talked about about the “de-stonkifying” of the market. The point is, this stuff is hard, and the people who have been building in public are hurting even as they spend billions to develop the tech. “ Crypto investment starts 2022 with a roar. ” my colleague Aisha notes. added things.

Marketing 246
article thumbnail

Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round

Xconomy

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma. Multiple myeloma affects about 300,000 Americans every year.